Product Reports Resources Pricing Login Book a demo

Granata Bio

Biotech & Life Sciences · Duxbury, United States · Founded 2018

Innovative solutions in reproductive health, enhancing drug discovery and clinical trials through strategic partnerships MoreLess

To find and grow fertility solutions for patients

Company overview

Granata Bio company information

The essential company record, classifications and operating signals in one place.

Status
Operational
Founded
2018
Headquarters
Duxbury, United States
Employees
18
Open positions
2
Dealroom signal
88.6
Investment activity
1 companies · latest Apr 2025
Capital deployed
Preferred round
ACQUISITION
client focusb2bsub industryPharmaceuticalsub industryBioTechnologybusiness modelManufacturingindustryHealthsectorBiotechnologysectorBiotech and PharmasectorHard TechsectorDT and LSsectorscience-based

Valuation & funding

Granata Bio funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES AEquity / VC Jan 2025 $15M $60M Amboy Street Ventures (ASV) · Gedeon Richter · CooperSurgical
SERIES AEquity / VC Jan 2024 $14M $56M Amboy Street Ventures (ASV) · Gedeon Richter · CooperSurgical · GV
Showing 2 recorded eventsUnlock the complete deal history →

Financials

Workforce over time

Available workforce history. Financial fields without reported data are omitted.

YearEmployees
2026 18
2025 15
2024 9
2023 5
2022 4
2021 3
2020 3
Company filings, research estimates and Dealroom dataOpen the full financial model →

Growth signals

Granata Bio website traffic

Latest recorded traffic for Granata Bio is 1.9K monthly website visits, down 17.4% over the last three months. Granata Bio's team grew 20% over the past year.

Latest monthly visits1.9K 3-month web change-17.4% 1-year team growth+20%
Monthly website visits35 observations · Jun 2022–Jul 2026
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

Granata Bio compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

CompanyHeadquartersStatusEmployeesTotal fundingValuation
New American TherapeuticsA privately held, specialty pharmaceutical company that acquires, markets and develops products in select therapeutic areas Parsippany-Troy Hills, United States Operational $53M
Steel TherapeuticsFocused on increasing access to life-changing therapies with a track record of efficacy from compounding pharmacies Iowa City, United States Operational
CellmAbsCellmabs is focused on researching and developing innovative biopharmaceuticals for the treatment of cancer Óbidos, Portugal Acquired
ImmuneOnco BiopharmaDedicated to the development and commercialization of novel cancer immunotherapy products designed to reverse cancer cell-induced immune inhibition and to actively eradicate cancer cells Huangpu, China Operational
AutolusProgrammed T-cell immunotherapies for cancer and autoimmune diseases London, United Kingdom Operational
UppertonPharmaceutical CDMO for oral and nasal dosage forms Nottingham, United Kingdom Operational
Caris Life SciencesA profiling platform that identifies novel molecular targets to inform and enhance drug development and advanced diagnostics Irving, United States Operational
Leap TherapeuticsA biopharmaceutical company in the clinical stage, acquiring and advancing innovative therapeutics at the forefront of cancer research Cambridge, United States Operational
Showing 8 of the closest matchesCompare every metric →

Capital deployed

Granata Bio investments and acquisitions

Recent portfolio relationships for companies that also act as investors or acquirers.

Talent graph

Granata Bio's talent

Book a demo to see the people
Team profiled 5 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 5 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

7 investors on Granata Bio's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Series A 6 investors entered at this stage
GV
Amboy Street Ventures (ASV)
Gedeon Richter
CooperSurgical
Alumni Ventures
Vibe Bio
Other known 1 additional known investor
What If Ventures

Global footprint

Where Granata Bio has talent and traffic

Workforce by country
5 countries with
team presence
🇺🇸 United States64.3%
🇨🇭 Switzerland14.3%
🇧🇷 Brazil7.1%
🇬🇧 United Kingdom7.1%
🇩🇪 Germany7.1%
5 countries shown

In the news

Latest news about Granata Bio

Recent press, funding announcements, and product moves mentioning Granata Bio — open to read from the original sources.

See all news

Market sentiment

What the market is saying about Granata Bio

An AI-synthesized read of the highest-engagement posts about Granata Bio on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Granata Bio’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.